← SynDRA
SELICICLIB
SynDRA canonical compound SYN0000761 — structure-anchored drug synonym record
| Clinical phase | Phase 2 |
|---|
| Primary target(s) | CDK9 |
|---|
| Mechanism of action | CDK inhibitor |
|---|
All known targets
Mechanisms of action (all sources)
- cyclin-dependent kinase inhibitor
- CDK2 INHIBITOR
- Cyclin-dependent kinase 2 inhibitor
- CDK7 INHIBITOR
- Cyclin-dependent kinase 7 inhibitor
- CDK9 INHIBITOR
- Cyclin-dependent kinase 9 inhibitor
- CDK1 INHIBITOR
- Cyclin-dependent kinase 1 inhibitor
- CDK5 INHIBITOR
- Cyclin-dependent kinase 5 inhibitor
Drug classes
- Antineoplastic Agents
- Antiviral Agents
- Protein Kinase Inhibitors
Cross-references
Synonyms
- CYC-202
- R-roscovitine
- Roscovitin
- Roscovitine
- AL-39256
- NSC-701554
- roscovitine
- (R)-roscovitine
- CYC202
- CYC 202
- 2-(R)-(1-Ethyl-2-hydroxyethylamino)-6-benzylamino-9-isopropylpurine
- UNII-0ES1C2KQ94
- Roscovitine (Seliciclib,CYC202)
- CHEMBL14762
- 0ES1C2KQ94
- CHEBI:45307
- NSC701554
- (2R)-2-[[6-(benzylamino)-9-isopropyl-purin-2-yl]amino]butan-1-ol
- (R)-2-((6-(Benzylamino)-9-isopropyl-9H-purin-2-yl)amino)butan-1-ol
- (2R)-2-[[6-(benzylamino)-9-propan-2-ylpurin-2-yl]amino]butan-1-ol
- RRC
- Rosco
- M02443
- BMK1-E12
- CYC202, Seliciclib, R-roscovitine, Roscovitine
- (2r)-2-{[6-(benzylamino)-9-isopropyl-9h-purin-2-yl]amino}-1-butanol
- 2-(R)-[[9-(1-Methylethyl)-6-[(phenylmethyl)amino]-9H-purin-2-yl]amino]-1-butanol
- 2-[[9-(1-Methylethyl)-6-[(phenylmethyl)amino]-9H-purin-2-yl]amino]-(R)-1-butanol
- 6-(Benzylamino)-2(R)-[[1-(hydroxymethyl)propyl]amino]-9-isopropylpurine
- R roscovitine
- NSC 701554
- seliciclibum
- RefChem:389269
- DTXCID8094419
- Seliciclib [INN]
- Seliciclib (Roscovitine)
- MFCD02266401
- C19H26N6O
- 1unl
Look up SELICICLIB in the interactive SynDRA portal →